Meyka Pro banner
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ILMNNASDAQ
HealthcareMedical - Diagnostics & Research
$219.40
$6.16(2.89%)
U.S. Market opens in 64h 17m

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap33.2B
P/E Ratio39.36
EPS (TTM)$5.03
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$199.31
3 Months$241.84
1 Year Target$136.02

ILMN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Illumina, Inc. (NASDAQ: ILMN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Illumina, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ILMN on the NASDAQ shows an RSI of 66.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $136.02 for the NASDAQ listing.

Key metrics behind Illumina, Inc.'s NASDAQ-traded stock include a P/E ratio of 39.36 and a market capitalization of 33.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ILMN on the NASDAQ.

Price Performance (NASDAQ: ILMN)

1-Day Change
2.89%
5-Day Change
15.44%
1-Month Change
13.96%
3-Month Change
51.49%
6-Month Change
86.45%
Year-to-Date (YTD) Change
67.28%
1-Year Change
120.97%
3-Year Change
34.86%
5-Year Change
-52.80%
All-Time (Max) Change
1052.92%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

86,000 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions